EMA — authorised 27 September 2019
- Marketing authorisation holder: Evolus Pharma Limited
- Status: approved
🇪🇺 Nuceiva in European Union
EMA authorised Nuceiva on 27 September 2019
Marketing authorisation
Nuceiva in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in European Union
Frequently asked questions
Is Nuceiva approved in European Union?
Yes. EMA authorised it on 27 September 2019.
Who is the marketing authorisation holder for Nuceiva in European Union?
Evolus Pharma Limited holds the EU marketing authorisation.